We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+2.21%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.6B
AUM Growth
-$32.5M
Cap. Flow
-$53.5M
Cap. Flow %
-3.33%
Top 10 Hldgs %
39.48%
Holding
157
New
3
Increased
26
Reduced
28
Closed
8

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$13.3M
2
LH icon
Labcorp
LH
+$11.2M
3
ILMN icon
Illumina
ILMN
+$9.43M
4
ALC icon
Alcon
ALC
+$2.47M
5
NVS icon
Novartis
NVS
+$1.79M

Sector Composition

Rank Sector Weight
1 Technology 39.5%
2 Healthcare 15.16%
3 Communication Services 12.78%
4 Financials 12.05%
5 Consumer Discretionary 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALC icon
76
Alcon
ALC
$33.1B
$2.61M 0.16%
+42,044
New +$2.47M
CRL icon
77
Charles River Laboratories
CRL
$10.9B
$2.55M 0.16%
17,995
UNH icon
78
UnitedHealth
UNH
$382B
$2.26M 0.14%
9,250
MRK icon
79
Merck
MRK
$324B
$2.17M 0.14%
27,059
+1,650
+6% +$126K
NXPI icon
80
NXP Semiconductors
NXPI
$68B
$2.06M 0.13%
21,120
JNJ icon
81
Johnson & Johnson
JNJ
$635B
$2.01M 0.13%
14,450
JPM icon
82
JPMorgan Chase
JPM
$939B
$1.9M 0.12%
17,000
CVS icon
83
CVS Health
CVS
$137B
$1.9M 0.12%
34,826
CRUS icon
84
Cirrus Logic
CRUS
$6.74B
$1.66M 0.1%
37,990
V icon
85
Visa
V
$677B
$1.65M 0.1%
9,502
SEDG icon
86
SolarEdge
SEDG
$2.59B
$1.56M 0.1%
24,965
BIDU icon
87
Baidu
BIDU
$35.8B
$1.52M 0.09%
12,980
+375
+3% +$53.4K
FFIV icon
88
F5
FFIV
$22.1B
$1.51M 0.09%
10,390
SIMO icon
89
Silicon Motion
SIMO
$9.19B
$1.42M 0.09%
32,060
AGN
90
DELISTED
Allergan plc
AGN
$1.42M 0.09%
8,500
DGX icon
91
Quest Diagnostics
DGX
$25.1B
$1.37M 0.09%
13,455
-11,245
-46% -$1.08M
LRCX icon
92
Lam Research
LRCX
$382B
$1.35M 0.08%
72,050
KLIC icon
93
Kulicke & Soffa
KLIC
$5.3B
$1.34M 0.08%
59,320
AEIS icon
94
Advanced Energy
AEIS
$12.2B
$1.3M 0.08%
23,030
UI icon
95
Ubiquiti
UI
$31.8B
$1.25M 0.08%
9,510
-3,700
-28% -$536K
SYK icon
96
Stryker
SYK
$127B
$1.25M 0.08%
6,060
FTNT icon
97
Fortinet
FTNT
$112B
$1.23M 0.08%
80,000
EGRX
98
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.12M 0.07%
20,185
+11,965
+146% +$624K
STI
99
DELISTED
SunTrust Banks, Inc.
STI
$1.12M 0.07%
17,752
-143,190
-89% -$9M
MA icon
100
Mastercard
MA
$477B
$1.09M 0.07%
4,139

Similar funds

Oak Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Oak Associates held 157 positions worth $1.6B, down 2% from $1.64B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Oak Associates withdrew a net $53.5M in Q2 2019, closing 8 positions and reducing 28 holdings. Its most notable exit was TCF Financial Corporation, an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Oak Associates opened a new position in Zimmer Biomet worth $13M.

  • Oak Associates's largest Q2 2019 buy was Zimmer Biomet: 113,718 shares worth $13M.
  • Oak Associates added most to Illumina in Q2 2019, an estimated $9.43M increase.
  • Oak Associates's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $23.6M.
  • Oak Associates fully exited TCF Financial Corporation in Q2 2019, selling an estimated $18.9M.
  • Oak Associates's ten largest holdings make up 39% of its $1.6B portfolio in Q2 2019.
  • Oak Associates opened 3 new positions and closed 8 in Q2 2019.
  • Oak Associates's portfolio value fell 2% quarter-over-quarter to $1.6B.

Based on Oak Associates's 13F filing for Q2 2019, filed 9 Aug 2019.